Adjuvant chemotherapy provides small absolute 8-year DMFS benefit in high-risk HR+ HER2- breast cancer
Trial shows limited chemotherapy benefit for some early breast cancer
This randomized controlled trial of 868 patients with HR+ HER2- breast cancer and a clinical high/genomic low-risk assessment found small ab…
New data suggests that some patients with early stage breast cancer may see very little benefit from chemotherapy based on specific genetic …
Zanidatamab with chemotherapy or tislelizumab achieves 70% objective response rate in HER2-positive gastroesophageal adenocarcinoma
New drug combination shows promise for advanced stomach cancer
This meta-analysis of 685 patients with advanced HER2-positive gastroesophageal adenocarcinoma found that zanidatamab combined with chemothe…
A new drug combination shows a 70% response rate for patients with a specific type of advanced stomach cancer, though it carries some risks.
Erdafitinib improves overall survival in FGFR3-altered urothelial carcinoma with HR 0.64 compared to chemotherapy
Trial shows erdafitinib improves survival for specific bladder cancers
In a randomized controlled trial of 266 patients with locally advanced or metastatic urothelial carcinoma and susceptible FGFR3 alterations,…
A new treatment called erdafitinib showed improved survival for patients with specific genetic markers in advanced urothelial carcinoma.
Retifanlimab plus carboplatin and paclitaxel improves progression-free survival in squamous cell carcinoma of the anal canal
New treatment option for advanced anal canal cancer patients
A randomized controlled trial and a single-arm trial evaluated retifanlimab in patients with metastatic or inoperable locally recurrent squa…
A new drug combination shows promise in slowing the progression of advanced anal canal cancer for patients with limited treatment options.
CRP and CT Guided Selective Ileostomy for Rectal Cancer Patients
Selective Ileostomy Strategy Reduces Stoma Needs for Rectal Cancer
A randomized trial shows that CRP and CT-guided selection significantly reduces ileostomy rates and improves patient quality of life.
A new guided approach for rectal cancer surgery significantly reduces the need for permanent stomas and improves patient quality of life.
PD-L1 and CTLA-4 Variants Linked to Genitourinary Cancer Risk
Genetic variations linked to risk of certain genitourinary cancers
A meta-analysis of 16 studies links PD-L1 and CTLA-4 variants to altered genitourinary cancer susceptibility, especially in Asian population…
Specific genetic markers in the PD-L1 and CTLA-4 genes are linked to different levels of risk for bladder, kidney, and prostate cancers.
Sulphur-handling gene program is lower in mesenchymal CMS4 colorectal cancer tumours than non-CMS4 tumours
Sulphur-handling Genes Show Link to Specific Colorectal Cancer Types
This meta-analysis of 1,337 tumours identifies a coordinated sulphur-handling transcriptional programme that is consistently lower in mesenc…
Researchers identified a specific group of genes related to how cells handle sulphur in certain types of colorectal cancer.
Post-operative ctDNA linked to worse survival in HPV-negative HNSCC, but estimate unstable
ctDNA levels may signal cancer return in head and neck cancer
This meta-analysis examined post-operative ctDNA as a prognostic marker in HPV-negative head and neck squamous cell carcinoma. Detectable ct…
Detecting traces of cancer DNA in the blood after surgery may help identify patients at higher risk of cancer returning.
Lower lenvatinib starting doses show no clear response benefit in advanced endometrial cancer
Lower Lenvatinib Doses Show No Extra Benefit for Endometrial Cancer
This meta-analysis of 10 observational cohorts (1,000 patients) examined whether starting lenvatinib below 20 mg affects outcomes in previou…
A review of 1,000 patients found that starting a lower dose of lenvatinib does not improve cancer control or response rates.
Uniportal video-assisted thoracoscopic surgery reduces postoperative pain, pneumonia, and hospital stay in esophageal cancer
One-Port Surgery May Reduce Pain and Stay for Esophageal Cancer
This meta-analysis compares uniportal video-assisted thoracoscopic surgery (uVATS) to multiportal video-assisted thoracoscopic surgery (mVAT…
A single-port surgical technique for esophageal cancer may reduce patient pain, pneumonia risk, and hospital stay compared to multi-port met…
EHR-integrated PROMs improve symptom monitoring and clinic efficiency in chronic condition management
Digital tools help doctors track symptoms for chronic conditions
This systematic review of 10 studies examined the impact of integrating patient-reported outcome measures (PROMs) into electronic health rec…
Integrating patient-reported outcomes into electronic health records can help doctors identify symptoms faster and improve clinic efficiency…
TAS-102 plus bevacizumab and fruquintinib significantly improve overall survival in metastatic colorectal cancer
Fruquintinib and TAS-102 Show Promise for Metastatic Colorectal Cancer
This systematic review and network meta-analysis of 3959 patients evaluated several treatments for metastatic colorectal cancer. The analysi…
New analysis shows fruquintinib and TAS-102 plus bevacizumab can improve survival for patients with metastatic colorectal cancer.